Pepstar

Organization

Heard in 2 episodes across 1 show since Oct 2026

Pepstar is a Shanghai-based biotechnology company that emerged from stealth after entering a reported $1.3 billion transaction with Gilead Sciences.

Episodes

across 1 show

First heard

Oct 2026

Expert statements

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data

Email alert

One email a week at most, with the new episodes that mention Pepstar. Free, no account needed, unsubscribe in one click.

1 statement · 1 neutral

Lauren MartzNeutralOct 27, 2026· BioCentury This Week
Pepstar’s oral IL-23 inhibitor lacked efficacy data and was in phase one testing.
“this is in, as I said, a phase one trial in healthy volunteers. We don't have any efficacy data”
Listen at 20:06
Open the episode · Ep. 394 - Security concerns in U.S., China reshaping biotech

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

2 episodes featuring Pepstar, newest first